Skip to main content
. 2015 Jun 22;35(11):1373–1385. doi: 10.1038/onc.2015.193

Table 1. Multivariable analysis.

mRNA cohort (n=170)
Protein cohort (n=170)
  AHRa P-value   AHR P-value
Age 0.98 (0.95, 1.02) 0.89 Age 1.03 (1.00, 1.13) 0.03
Tumor size 1.63 (1.11, 2.63) 0.01    
Endocrine therapy     Endocrine therapy    
 No    No  
 Yes 0.86 (0.35, 1.43) 0.69  Yes 0.68 (0.18, 2.76) 0.69
Grade     AJCC stage    
 2 0.77 (0.40, 1.67) 0.75  1  
 3 1.40 (0.49, 5.39) 0.19  2 1.64 (0.48, 3.48) 0.21
CK5/BCL6-related risk     CK5/BCL6-related risk    
 Low    Low  
 High 4.34 (2.06, 18.39) <0.001  High 5.23 (1.89, 16.37) 0.004
a

Adjusted hazard ratio.